For: | Hwang SJ, Luo JC, Li CP, Chu CW, Wu JC, Lai CR, Chiang JH, Chau GY, Lui WY, Lee CC, Chang FY, Lee SD. Thrombocytosis: A paraneoplastic syndrome in patients with hepatocellular carcinoma. World J Gastroenterol 2004; 10(17): 2472-2477 [PMID: 15300887 DOI: 10.3748/wjg.v10.i17.2472] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i17/2472.htm |
Number | Citing Articles |
1 |
Rommaneeya LEELA-ARPORN, Hiroshi OHTA, Masahiro TAMURA, Noriyuki NAGATA, Kazuyoshi SASAOKA, Angkhana DERMLIM, Khoirun NISA, Keitaro MORISHITA, Noboru SASAKI, Kensuke NAKAMURA, Satoshi TAKAGI, Kenji HOSOYA, Mitsuyoshi TAKIGUCHI. Predictive factors of malignancy in dogs with focal liver lesions using clinical data and ultrasonographic features. Journal of Veterinary Medical Science 2019; 81(5): 723 doi: 10.1292/jvms.18-0673
|
2 |
Qinghua Shu, Nannan Zhang, Jianbo Han, Xiaopeng Yan, Bowen Sha, Liang Zhao, Yongxiang Yi, Yufeng Zhang. Novel predictive nomograms based on aspartate aminotransferase‑to‑platelet ratio index for hepatocellular carcinoma with post‑operative adjuvant transarterial chemoembolization. Oncology Letters 2023; 27(1) doi: 10.3892/ol.2023.14137
|
3 |
Alberto Zanetto, Elena Campello, Filippo Pelizzaro, Fabio Farinati, Patrizia Burra, Paolo Simioni, Marco Senzolo. Haemostatic alterations in patients with cirrhosis and hepatocellular carcinoma: laboratory evidence and clinical implications. Liver International 2022; 42(6): 1229 doi: 10.1111/liv.15183
|
4 |
Brian I. Carr, Vito Guerra, Edoardo G. Giannini, Fabio Farinati, Francesca Ciccarese, Gian Ludovico Rapaccini, Maria Di Marco, Luisa Benvegnù, Marco Zoli, Franco Borzio, Eugenio Caturelli, Maria Chiaramonte, Franco Trevisani. Significance of Platelet and AFP Levels and Liver Function Parameters for HCC Size and Survival. The International Journal of Biological Markers 2014; 29(3): 215 doi: 10.5301/jbm.5000064
|
5 |
Martina Casari, Dominik Siegl, Carsten Deppermann, Detlef Schuppan. Macrophages and platelets in liver fibrosis and hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1277808
|
6 |
Rajagopal Aravalli, Clifford Steer. Immune-Mediated Therapies for Liver Cancer. Genes 2017; 8(2): 76 doi: 10.3390/genes8020076
|
7 |
Yu-Liang Zhang, Zi-Rong Liu, Zhi Liu, Yi Bai, Hao Chi, Da-Peng Chen, Ya-Min Zhang, Zi-Lin Cui. Risk of cardiovascular death in patients with hepatocellular carcinoma based on the Fine-Gray model. World Journal of Gastrointestinal Oncology 2024; 16(3): 844-856 doi: 10.4251/wjgo.v16.i3.844
Abstract(250) |
Core Tip(219) |
Full Article(HTML)(1100)
|
Full Article with Cover (PDF)-2857K(44)
|
Full Article (Word)-700K(0)
|
Audio-611K(0)
|
Peer-Review Report-220K(26)
|
Answering Reviewers-80K(20)
|
Supplementary Material-88K(25)
|
Full Article (PDF)-2590K(46)
|
Full Article (XML)-139K(22)
|
Times Cited (1)
|
Total Visits (3081)
|
Open
|
8 |
Chih-Cheng Hsiao, Jiin-Haur Chuang, Mao-Ming Tiao, Jiunn-Ming Sheen, Chie-Song Shieh. Patterns of Hepatoblastoma and Hepatocellular Carcinoma in Children After Universal Hepatitis B Vaccination in Taiwan. Journal of Pediatric Hematology/Oncology 2009; 31(2): 91 doi: 10.1097/MPH.0b013e31818b3784
|
9 |
Ashley N. Davis, Vahid Afshar-Kharghan, Anil K. Sood. Platelet Effects on Ovarian Cancer. Seminars in Oncology 2014; 41(3): 378 doi: 10.1053/j.seminoncol.2014.04.004
|
10 |
|
11 |
Mark Babyatsky. Syndrome of Inappropriate Anti-Diuretic Hormone Secondary to Non-Cirrhotic Primary Hepatocellular Carcinoma. American Journal of Case Reports 2015; 16: 31 doi: 10.12659/AJCR.892370
|
12 |
Hiroki Tanaka, Kie Horioka, Masahiro Yamamoto, Masaru Asari, Katsuhiro Okuda, Kosuke Yamazaki, Keiko Shimizu, Katsuhiro Ogawa. Overproduction of thrombopoietin by BRAFV600E‐mutated mouse hepatocytes and contribution of thrombopoietin to hepatocarcinogenesis. Cancer Science 2019; 110(9): 2748 doi: 10.1111/cas.14130
|
13 |
Pik Eu Chang, Wai Choung Ong, Hock Foong Lui, Chee Kiat Tan. Epidemiology and Prognosis of Paraneoplastic Syndromes in Hepatocellular Carcinoma. ISRN Oncology 2013; 2013: 1 doi: 10.1155/2013/684026
|
14 |
Anastasia Lemekhova, Daniel Hornuss, Georgios Polychronidis, Philipp Mayer, Christian Rupp, Thomas Longerich, Karl-Heinz Weiss, Markus Büchler, Arianeb Mehrabi, Katrin Hoffmann. Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01855-2
|
15 |
Iman Attia Abdelgawad. Clinical utility of simple non-invasive liver fibrosis indices for predicting hepatocellular carcinoma (HCC) among Egyptian patients. Journal of Clinical Pathology 2015; 68(2): 154 doi: 10.1136/jclinpath-2014-202462
|
16 |
A.D Woolcock, A. Keenan, C. Cheung, J.A. Christian, G.E. Moore. Thrombocytosis in 715 Dogs (2011–2015). Journal of Veterinary Internal Medicine 2017; 31(6): 1691 doi: 10.1111/jvim.14831
|
17 |
Sun Young Cho, John Jeongseok Yang, Eunkyoung You, Byung-Ho Kim, Jaejun Shim, Hee Joo Lee, Woo-In Lee, Jin-Tae Suh, Tae Sung Park. Mean platelet volume/platelet count ratio in hepatocellular carcinoma. Platelets 2013; 24(5): 375 doi: 10.3109/09537104.2012.701028
|
18 |
R. Leela-arporn, H. Ohta, N. Nagata, K. Sasaoka, M. Tamura, A. Dermlim, K. Nisa, K. Morishita, N. Sasaki, K. Nakamura, S. Takagi, K. Hosoya, M. Takiguchi. Epidemiology of massive hepatocellular carcinoma in dogs: A 4-year retrospective study. The Veterinary Journal 2019; 248: 74 doi: 10.1016/j.tvjl.2019.04.011
|
19 |
Christopher Schrecker, Oliver Waidmann, Hanan El Youzouri, Jörg Trojan, Andreas Anton Schnitzbauer, Wolf Otto Bechstein, Stefan Zeuzem, Christine Koch. Low Platelet Count Predicts Reduced Survival in Potentially Resectable Hepatocellular Carcinoma. Current Oncology 2022; 29(3): 1475 doi: 10.3390/curroncol29030124
|
20 |
Chhagan Bihari, Archana Rastogi, Saggere Muralikrishna Shasthry, Meenu Bajpai, Ajeet Singh Bhadoria, S. Rajesh, Amar Mukund, Anupam Kumar, Shiv K. Sarin. Platelets contribute to growth and metastasis in hepatocellular carcinoma. APMIS 2016; 124(9): 776 doi: 10.1111/apm.12574
|
21 |
Brian I. Carr, Vito Guerra. Thrombocytosis and Hepatocellular Carcinoma. Digestive Diseases and Sciences 2013; 58(6): 1790 doi: 10.1007/s10620-012-2527-3
|
22 |
Ao Ren, Zhongqiu Li, Xuzhi Zhang, Ronghai Deng, Yi Ma. <p>Inflammation-Based Prognostic Scores in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma After Liver Transplantation</p>. Journal of Hepatocellular Carcinoma 2020; : 101 doi: 10.2147/JHC.S259992
|
23 |
Erin A. Gibson, Roger E. Goldman, William T. N. Culp. Comparative Oncology: Management of Hepatic Neoplasia in Humans and Dogs. Veterinary Sciences 2022; 9(9): 489 doi: 10.3390/vetsci9090489
|
24 |
Janet Beeler-Marfisi, Luis Arroyo, Jeff L. Caswell, Josepha DeLay, Dorothee Bienzle. Equine Primary Liver Tumors: A Case Series and Review of the Literature. Journal of Veterinary Diagnostic Investigation 2010; 22(2): 174 doi: 10.1177/104063871002200202
|
25 |
Brian I. Carr. Guest Editorial: Platelets and Cancer. Seminars in Oncology 2014; 41(3): 300 doi: 10.1053/j.seminoncol.2014.04.011
|
26 |
Carrie Kavanagh, Scott Shaw, Cynthia R.L. Webster. Coagulation in hepatobiliary disease. Journal of Veterinary Emergency and Critical Care 2011; 21(6): 589 doi: 10.1111/j.1476-4431.2011.00691.x
|
27 |
Norbert Bräu, Rena K. Fox, Peiying Xiao, Kristen Marks, Zeenat Naqvi, Lynn E. Taylor, Anita Trikha, Morris Sherman, Mark S. Sulkowski, Douglas T. Dieterich, Michael O. Rigsby, Teresa L. Wright, Maria D. Hernandez, Mamta K. Jain, Gajendra K. Khatri, Richard K. Sterling, Maurizio Bonacini, Catherine A. Martyn, Ayse Aytaman, Josep M. Llovet, Sheldon T. Brown, Edmund J. Bini. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.–Canadian multicenter study. Journal of Hepatology 2007; 47(4): 527 doi: 10.1016/j.jhep.2007.06.010
|
28 |
Natasa Pavlovic, Bhavna Rani, Pär Gerwins, Femke Heindryckx. Platelets as Key Factors in Hepatocellular Carcinoma. Cancers 2019; 11(7): 1022 doi: 10.3390/cancers11071022
|
29 |
Zhao‐Chong Zeng, Jia Fan, Zhao‐You Tang, Jian Zhou, Jian‐Hua Wang, Bin‐Liang Wang, Wei Guo. Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external‐beam radiation therapy. Cancer Science 2008; 99(12): 2510 doi: 10.1111/j.1349-7006.2008.00981.x
|
30 |
Robert Fathke, Ze Peng, Basil Golding, Chava Kimchi‐Sarfaty. The Liver. 2009; : 639 doi: 10.1002/9780470747919.ch41
|
31 |
Neil B. Newman, Salma K. Jabbour, Jane Date C. Hon, Joseph J. Berman, Deen Malik, Darren Carpizo, Rebecca A. Moss. Hepatocellular Carcinoma Without Cirrhosis Presenting With Hypercalcemia: Case Report and Literature Review. Journal of Clinical and Experimental Hepatology 2015; 5(2): 163 doi: 10.1016/j.jceh.2015.04.001
|
32 |
Marcela Natacha Aparecida Rocha, Mayara Carvalho de Sousa Rocha, Mayara Lima Kavasaki, Juliana Yuki Rodrigues, Weyber Ferreira de Souza, Adriane Jorge Mendonça. THROMBOCYTOSIS: A RETROSPECTIVE STUDY OF 573 DOGS (2016-2017). Ciência Animal Brasileira 2019; 20 doi: 10.1590/1089-6891v20e-51837
|
33 |
Romeo-Gabriel Mihăilă. A Look at Platelet Count in Chronic Hepatitis C Infection. EMJ Hepatology 2017; : 97 doi: 10.33590/emjhepatol/10310346
|
34 |
|
35 |
Magdy Hamed Attwa, Shahira Aly El-Etreby. Guide for diagnosis and treatment of hepatocellular carcinoma. World Journal of Hepatology 2015; 7(12): 1632-1651 doi: 10.4254/wjh.v7.i12.1632
|
36 |
|
37 |
Catia Lippolis, Maria Grazia Refolo, Rosalba D’Alessandro, Nicola Carella, Caterina Messa, Aldo Cavallini, Brian Irving Carr. Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1. Journal of Experimental & Clinical Cancer Research 2015; 34(1) doi: 10.1186/s13046-015-0210-1
|
38 |
Yuki Ong, Cheong Wei Terence Huey, Vishalkumar Girishchandra Shelat. Paraneoplastic syndromes in hepatocellular carcinoma: a review. Expert Review of Gastroenterology & Hepatology 2022; 16(5): 449 doi: 10.1080/17474124.2022.2085556
|
39 |
C.-C. Chen, J.-Y. Chang, K.-J. Liu, C. Chan, C.-H. Ho, S.-C. Lee, L.-T. Chen. Hepatocellular carcinoma associated with acquired von Willebrand disease and extreme thrombocytosis. Annals of Oncology 2005; 16(6): 988 doi: 10.1093/annonc/mdi171
|
40 |
Po‐Hong Liu, Chia‐Yang Hsu, Chien‐Wei Su, Yi‐Hsiang Huang, Ming‐Chih Hou, Nicole E. Rich, Naoto Fujiwara, Yujin Hoshida, Amit G. Singal, Teh‐Ia Huo. Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma. Liver International 2020; 40(10): 2522 doi: 10.1111/liv.14560
|
41 |
D. Arioli, M. Pipino, E. Boldrini, E. Amateis, A. Cristani, P. Ventura, E. Romagnoli, M. C. De Santis, M. L. Zeneroli. Tumour markers in internal medicine: a low-cost test or an unnecessary expense? A retrospective study based on appropriateness. Internal and Emergency Medicine 2007; 2(2): 88 doi: 10.1007/s11739-007-0028-8
|
42 |
Youwei Wu, Wei Peng, Junyi Shen, Xiaoyun Zhang, Chuan Li, Tian-fu Wen. Prognostic nomograms for HBV-related BCLC 0-a stage hepatocellular carcinoma incorporating aspartate aminotransferase to albumin ratio. Scandinavian Journal of Gastroenterology 2023; 58(7): 789 doi: 10.1080/00365521.2023.2165417
|
43 |
Rong Li, Meiping Ren, Ni Chen, Mao Luo, Xin Deng, Jiyi Xia, Guang Yu, Jinbo Liu, Bing He, Xu Zhang, Zhuo Zhang, Xiao Zhang, Bing Ran, Jianbo Wu. Presence of intratumoral platelets is associated with tumor vessel structure and metastasis. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-167
|
44 |
Rosalba D’Alessandro, Maria Grazia Refolo, Catia Lippolis, Nicola Carella, Caterina Messa, Aldo Cavallini, Brian Irving Carr. Modulation of Regorafenib effects on HCC cell lines by epidermal growth factor. Cancer Chemotherapy and Pharmacology 2015; 75(6): 1237 doi: 10.1007/s00280-015-2751-6
|
45 |
Marc A. Brockmann, Alf Giese, Kathrin Mueller, Finjap janvier Kaba, Frank Lohr, Christel Weiss, Stefan Gottschalk, Ingo Nolte, Jan Leppert, Jochen Tuettenberg, Christoph Groden. Preoperative thrombocytosis predicts poor survival in patients with glioblastoma. Neuro-Oncology 2007; 9(3): 335 doi: 10.1215/15228517-2007-013
|
46 |
Tiziano Barbui, Guido Finazzi, Ayalew Tefferi. Platelets. 2019; : 863 doi: 10.1016/B978-0-12-813456-6.00047-3
|
47 |
Yakup Ülger, Anil Delik. Paraneoplastic syndrome frequency and prognostic effect in hepatocellular carcinoma patients. European Journal of Gastroenterology & Hepatology 2022; 34(7): 769 doi: 10.1097/MEG.0000000000002341
|
48 |
Felice Giuliante, Agostino Maria De Rose, Vito Guerra, Francesco Ardito, Gennaro Nuzzo, Brian I. Carr. Clinical Characteristics and Survival of European Patients with Resectable Large Hepatocellular Carcinomas. Journal of Gastrointestinal Cancer 2013; 44(3): 329 doi: 10.1007/s12029-013-9523-5
|
49 |
Labrini V Athanasiou, Zoe S Polizopoulou, Eleftheria G Papavasileiou, Efstathios L Mpairamoglou, Maria C Kantere, Xanthi A Rousou. Magnitude of reactive thrombocytosis and associated clinical conditions in dogs. Veterinary Record 2017; 181(10): 267 doi: 10.1136/vr.104042
|
50 |
Rosalba D’Alessandro, Maria G Refolo, Catia Lippolis, Grazia Giannuzzi, Nicola Carella, Caterina Messa, Aldo Cavallini, Brian I Carr. Antagonism of Sorafenib and Regorafenib actions by platelet factors in hepatocellular carcinoma cell lines. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-351
|
51 |
Aarti Tyagi, Anjali Gupta. Comparision of coagulation profile trends in case of liver cirrhosis with HCC versus cirrhosis without HCC: Analysis of 150 cases in a tertiary health care. IP Journal of Diagnostic Pathology and Oncology 2023; 8(4): 209 doi: 10.18231/j.jdpo.2023.049
|
52 |
Gail E. Tomlinson, Heung Bae Kim. Oncology of Infancy and Childhood. 2009; : 721 doi: 10.1016/B978-1-4160-3431-5.00018-2
|
53 |
David J. Powner, W. Keith Hoots. Thrombocytosis in the NICU. Neurocritical Care 2008; 8(3): 471 doi: 10.1007/s12028-008-9076-9
|
54 |
Alassan Kouame Mahassadi, Henriette Anzouan-Kacou Kissi, Alain Koffi Attia. The Prognostic Values of Neutrophil-to-lymphocyte Ratio and Platelet-to-Lymphocyte Ratio at Baseline in Predicting the In-hospital Mortality in Black African Patients with Advanced Hepatocellular Carcinoma in Palliative Treatment: A Comparative Cohort Study. Hepatic Medicine: Evidence and Research 2021; : 123 doi: 10.2147/HMER.S333980
|
55 |
Edris M. Alkozai, Robert J. Porte, Jelle Adelmeijer, Alberto Zanetto, Paolo Simioni, Marco Senzolo, Ton Lisman. No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma. Thrombosis Research 2015; 135(2): 292 doi: 10.1016/j.thromres.2014.11.016
|
56 |
Alberto Zanetto, Marco Senzolo, Alessandro Vitale, Umberto Cillo, Claudia Radu, Francesca Sartorello, Luca Spiezia, Elena Campello, Kryssia Rodriguez-Castro, Alberto Ferrarese, Fabio Farinati, Patrizia Burra, Paolo Simioni. Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma. Digestive and Liver Disease 2017; 49(4): 440 doi: 10.1016/j.dld.2016.12.019
|
57 |
Gabrielle S. Fontes, Vincent A. Wavreille, Janis M. Lapsley, Edward S. Cooper, Julien Guillaumin, Laura E. Selmic. Thromboelastographic results and hypercoagulability in dogs with surgically treated hepatocellular adenoma and carcinoma: A Veterinary Society of Surgical Oncology prospective study. Veterinary and Comparative Oncology 2023; 21(4): 616 doi: 10.1111/vco.12924
|
58 |
Alberto Zanetto, Elena Campello, Luca Spiezia, Patrizia Burra, Paolo Simioni, Francesco Paolo Russo. Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma. Cancers 2018; 10(11): 450 doi: 10.3390/cancers10110450
|
59 |
Jessica Seeßle, Jan Löhr, Marietta Kirchner, Josefin Michaelis, Uta Merle. Assessment of rotational thrombelastometry (ROTEM) parameters in hepatocellular carcinoma. Thrombosis Research 2020; 195: 55 doi: 10.1016/j.thromres.2020.07.006
|
60 |
Beatriz Vieira Neto, Valéria Tavares, Joana M. O. Santos, Fátima Cerqueira, Deolinda Pereira, Rui Medeiros. Map of thrombogenesis in viral infections and viral-driven tumours. Discover Oncology 2023; 14(1) doi: 10.1007/s12672-022-00610-1
|
61 |
|
62 |
Metwaly Khaled, Abdel Sameea Eman, El-Azab Gasser, Assem Medhat, Abbas Mohamed, Zakareya Talaat, Abo Raia Gamal. Mean platelet volume and mean platelet volume/platelet count ratio as markers for hepatocellular carcinoma in patients with chronic hepatitis C virus related cirrhosis. Journal of Cancer Research and Experimental Oncology 2016; 8(4): 33 doi: 10.5897/JCREO2016.0135
|
63 |
Alberto Zanetto, Marco Senzolo, Elena Campello, Cristiana Bulato, Sabrina Gavasso, Sarah Shalaby, Martina Gambato, Alessandro Vitale, Umberto Cillo, Fabio Farinati, Francesco Paolo Russo, Paolo Simioni, Patrizia Burra. Influence of Hepatocellular Carcinoma on Platelet Aggregation in Cirrhosis. Cancers 2021; 13(5): 1150 doi: 10.3390/cancers13051150
|
64 |
Paola Pradella, Stefania Bonetto, Stefano Turchetto, Laura Uxa, Consuelo Comar, Francesca Zorat, Vincenzo De Angelis, Gabriele Pozzato. Platelet production and destruction in liver cirrhosis. Journal of Hepatology 2011; 54(5): 894 doi: 10.1016/j.jhep.2010.08.018
|
65 |
L Purnima Devi, Ritesh Kumar, Akash Handique, Mahendra Kumar. Hepatoblastoma—a Rare Liver Tumor with Review of Literature. Journal of Gastrointestinal Cancer 2014; 45(S1): 261 doi: 10.1007/s12029-014-9659-y
|
66 |
Meng Zhang, Ya-Ping Li, Na He, Shuang-Suo Dang. Platelets in liver cancer. World Chinese Journal of Digestology 2024; 32(10): 735 doi: 10.11569/wcjd.v32.i10.735
|
67 |
Ahmed Muhammad Bashir, Abdirashid Hashi Mohamed, Hawa Nuradin Mohamed, Ismail Gedi Ibrahim. Severe Hypercalcemia as an Initial Presentation of Advanced Hepatocellular Carcinoma: A Case Report. Cancer Management and Research 2022; : 1577 doi: 10.2147/CMAR.S364996
|
68 |
Christopher Schrecker, Falko Schulze, Jörg Trojan, Wolf Otto Bechstein, Stefan Zeuzem, Christine Koch. Diagnostic performance of non-invasive liver fibrosis scores in patients with early-intermediate hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2024; 150(4) doi: 10.1007/s00432-024-05708-3
|
69 |
Chandan Sanghera, Jhia J. Teh, David J. Pinato. The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma. Liver International 2019; 39(11): 2008 doi: 10.1111/liv.14220
|
70 |
Zsolt Baranyai, Valéria Jósa, Ambrus Tóth, Zsuzsanna Szilasi, Balazs Tihanyi, Attila Zaránd, Laszlo Harsanyi, Zoltán Szállási. Paraneoplastic thrombocytosis in gastrointestinal cancer. Platelets 2016; 27(4): 269 doi: 10.3109/09537104.2016.1170112
|
71 |
Shun-Li Shen, Shun-Jun Fu, Bin Chen, Ming Kuang, Shao-Qiang Li, Yun-Peng Hua, Li-Jian Liang, Pi Guo, Yuantao Hao, Bao-Gang Peng. Preoperative Aspartate Aminotransferase to Platelet Ratio is an Independent Prognostic Factor for Hepatitis B-Induced Hepatocellular Carcinoma After Hepatic Resection. Annals of Surgical Oncology 2014; 21(12): 3802 doi: 10.1245/s10434-014-3771-x
|
72 |
Ganiy Opeyemi Abdulrahman, Nagindra Das, K Lutchman Singh. The predictive role of thrombocytosis in benign, borderline and malignant ovarian tumors. Platelets 2020; 31(6): 795 doi: 10.1080/09537104.2019.1686755
|
73 |
David J. Pinato, Rohini Sharma. Hepatocellular Carcinoma. 2016; : 229 doi: 10.1007/978-3-319-34214-6_15
|